Norris Medicines informs about unaudited financial results

11 Nov 2022 Evaluate
Pursuant to Regulation 33 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, Norris Medicines has informed that it enclosed Standalone Un-audited Financial Results of the Company for the Quarter ended on 30th September, 2022; Limited Review Report on Standalone Un-audited Financial Results for the quarter ended on 30th September, 2022.

The above information is a part of company’s filings submitted to BSE.

Norris Medicines Share Price

15.00 0.33 (2.25%)
05-Dec-2025 16:59 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1804.95
Dr. Reddys Lab 1275.05
Cipla 1520.55
Zydus Lifesciences 931.45
Lupin 2097.65
View more..
Register Now to get our Free Newsletter & much more!

© 2025 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.

×